NIAID Banner Logo Image

ONLINE DATABASE SEARCH -HIV-LS-344-MEMO

1. 48605 HIV-LS-344; PUBMED-HIV-3/20/2006

The effect of a methyl or 2-fluoroethyl substituent at the N-3 position of thymidine, 3'-fluoro-3'-deoxythymidine and 1-beta-D-arabinosylthymine on their antiviral and cytostatic activity in cell culture

Balzarini, J, Celen, S, Karlsson, A, de Groot, T, Verbruggen, A, and Bormans, G

Antivir Chem Chemother 2006. 17(1): 17-23


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16542002&dopt=abstract


2. 48606 HIV-LS-344; PUBMED-HIV-3/20/2006

Inhibition of HIV-1 replication by oligonucleotide analogues directed to the packaging signal and trans-activating response region

Brown, DE, Arzumanov, A, Syed, S, Gait, MJ, and Lever, AM

Antivir Chem Chemother 2006. 17(1): 1-9


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16542000&dopt=abstract


3. 48607 HIV-LS-344; PUBMED-HIV-3/20/2006

Highly Potent and Orally Active CCR5 Antagonists as Anti-HIV-1 Agents: Synthesis and Biological Activities of 1-Benzazocine Derivatives Containing a Sulfoxide Moiety

Seto, M, Aikawa, K, Miyamoto, N, Aramaki, Y, Kanzaki, N, Takashima, K, Kuze, Y, Iizawa, Y, Baba, M, and Shiraishi, M

J Med Chem 2006. 49(6): 2037-2048


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16539392&dopt=abstract


4. 48608 HIV-LS-344; PUBMED-HIV-3/20/2006

Novel Bifunctional Quinolonyl Diketo Acid Derivatives as HIV-1 Integrase Inhibitors: Design, Synthesis, Biological Activities, and Mechanism of Action

Di Santo, R, Costi, R, Roux, A, Artico, M, Lavecchia, A, Marinelli, L, Novellino, E, Palmisano, L, Andreotti, M, Amici, R, Galluzzo, CM, Nencioni, L, Palamara, AT, Pommier, Y, and Marchand, C

J Med Chem 2006. 49(6): 1939-1945


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16539381&dopt=abstract


5. 48609 HIV-LS-344; EMBASE-HIV-3/20/2006

Inhibition of HIV entry by carbohydrate-binding proteins

Balzarini, J

Antiviral Research 2006. In Press, Uncorrected Proof


HYPERLINK:

http://www.sciencedirect.com/science/article/B6T2H-4JF8G1R-1/2/60befe4b223aa7be66ed1d6de0c3e6bf



6. 48610 HIV-LS-344; PUBMED-HIV-3/20/2006

New HIV-1 reverse transcriptase inhibitors based on a tricyclic benzothiophene scaffold: Synthesis, resolution, and inhibitory activity

Krajewski, K, Zhang, Y, Parrish, D, Deschamps, J, Roller, PP, and Pathak, VK

Bioorg Med Chem Lett 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16527484&dopt=abstract


7. 48611 HIV-LS-344; PUBMED-HIV-3/20/2006

A fluorescence polarization assay for screening inhibitors against the ribonuclease H activity of HIV-1 reverse transcriptase

Nakayama, GR, Bingham, P, Tan, D, and Maegley, KA

Anal Biochem 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16527235&dopt=abstract


8. 48612 HIV-LS-344; PUBMED-HIV-3/20/2006

Design, synthesis, and biological evaluation of chicoric acid analogs as inhibitors of HIV-1 integrase

Charvat, TT, Lee, DJ, Robinson, WE, and Chamberlin, AR

Bioorg Med Chem 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16524737&dopt=abstract


9. 48613 HIV-LS-344; PUBMED-HIV-3/20/2006

Structure-activity relationships of anti-HIV-1 peptides with disulfide linkage between D- and L-cysteine at positions i and i+3, respectively, derived from HIV-1 gp41 C-peptide

Lee, MK, Kim, HK, Lee, TY, Hahm, KS, and Kim, KL

Exp Mol Med 2006. 38(1): 18-26


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16520549&dopt=abstract


10. 48614 HIV-LS-344; EMBASE-HIV-3/20/2006

The HIV-1 reverse transcriptase mutants G190S and G190A, which confer resistance to non-nucleoside reverse transcriptase inhibitors, demonstrate reductions in RNase H activity and DNA synthesis from tRNALys, 3 that correlate with reductions in replication efficiency

Wang, J, Dykes, C, Domaoal, RA, Koval, CE, Bambara, RA, and Demeter, LM

Virology 2006. In Press, Corrected Proof


HYPERLINK:

http://www.sciencedirect.com/science/article/B6WXR-4JCBN4M-2/2/a604d73efcfd26101a6d40d48f6e92d4



11. 48615 HIV-LS-344; PUBMED-HIV-3/20/2006

Antiviral properties of two trimeric recombinant gp41 proteins

Delcroix-Genete, D, Quan, PL, Roger, MG, Hazan, U, Nisole, S, and Rousseau, C

Retrovirology 2006. 3(1): 16


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16515685&dopt=abstract


12. 48616 HIV-LS-344; PUBMED-HIV-3/20/2006

Dynamic pharmacophore model optimization: identification of novel HIV-1 integrase inhibitors

Deng, J, Sanchez, T, Neamati, N, and Briggs, JM

J Med Chem 2006. 49(5): 1684-92


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16509584&dopt=abstract


13. 48617 HIV-LS-344; PUBMED-HIV-3/20/2006

Synthesis and anti-HIV-1 and anti-HCMV activity of 1-substituted 3-(3,5-dimethylbenzyl)uracil derivatives

Maruyama, T, Kozai, S, Demizu, Y, Witvrouw, M, Pannecouque, C, Balzarini, J, Snoecks, R, Andrei, G, and De, Clercq E

Chem Pharm Bull (Tokyo) 2006. 54(3): 325-33


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16508186&dopt=abstract


14. 48618 HIV-LS-344; PUBMED-HIV-3/20/2006

Rubriflordilactones a and B, two novel bisnortriterpenoids from schisandrarubriflora and their biological activities

Xiao, WL, Yang, LM, Gong, NB, Wu, L, Wang, RR, Pu, JX, Li, XL, Huang, SX, Zheng, YT, Li, RT, Lu, Y, Zheng, QT, and Sun, HD

Org Lett 2006. 8(5): 991-4


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16494492&dopt=abstract


15. 48619 HIV-LS-344; WOS-HIV-3/12/2006

Dexelvucitabine - Anti-HIV agent - Reverse transcriptase inhibitor

McIntyre, JA and Castaner, J

DRUGS OF THE FUTURE 2005. 30(12): 1205-1211, 7


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000235583600001



16. 48620 HIV-LS-344; WOS-HIV-3/12/2006

Discovery of a highly potent and orally active CCR5 antagonist TAK-652 as an anti-HIV-1 agent: Synthesis and biological activities of 1-benzazocine derivatives containing a sulfoxide moiety

Seto, M, Aikawa, K, Aramaki, Y, Miyamoto, N, Kanzaki, N, Kuze, Y, Takashima, K, Baba, M, and Shiraishi, M

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 2005. 229: U122-1


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000235066600088


17. 48621 HIV-LS-344; WOS-HIV-3/12/2006

Prodrugs of 1-(beta-d-dioxolane)thymine (DOT): Synthesis, anti-HIV-1 activity and stability study

Liang, YZ, Yadav, V, Schinazi, RF, and Chu, CK

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 2005. 229: U168-1


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000235066600333


18. 48622 HIV-LS-344; WOS-HIV-3/19/2006

In vitro development of resistance to human immunodeficiency virus protease inhibitor GW640385

Yates, PJ, Hazen, R, St, Clair M, Boone, L, Tisdale, M, and Elston, RC

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2006. 50(3): 1092-1095, 4


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000235786300039


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2021